LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
12/04/2024
Voltar para busca
Dado oficial do USPTO
EITAN MEDICAL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
51
Atualização mais recente
12/04/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
10, 42
Data de depósito
14/02/2021
Data de registro
01/11/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
01/11/2022
Última transação
01/11/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
03
Localização do titular
IL
Examinador
SOUDERS, MICHAEL
Unidade examinadora
M60
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording "EITAN MEDICAL" stacked vertically. To the left of the wording are two circles appearing above an infinity symbol.
Titulares e representantes
Titulares
Eitan Medical Ltd
Representantes
Avital (Tally) Eitan GORNITZKY & CO.
Classificação técnica
Classes Nice
Classe 10Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 10
Medicalveterinary and surgical apparatus and instrumentsinfusion and injection devices for administering fluiddrugs and nutrition and parts and accessories for use with these instruments; Drug delivery devices and their compatible disposablessold emptysyringesinfusion setsfilling bagscartridgesadministration setsconnectorstubingcassettespumping connectorsvalvesfilters for carrying and delivering pharmaceuticalsfluidsdrugs and nutrition for medical treatment with integrated recorded software for monitoringtrackinggatheringtransmittingcontrollingprocessingmeasuring and managing data regarding the delivery of pharmaceuticalsdrugsfluids and nutrition into the patientthe performance of the medical delivery devicesthe patient's behaviorreaction toconsumption and effectiveness of the pharmaceuticalsdrugsfluids and nutrition provided to the patient via medical delivery devicessold as a unit therewith; drug delivery devices sold emptycatheterspen needlesinjection needlessyringespatchesinfusion pumpspatch pumpswearable injectorshandheld injectors; medical syringes infusion sets; lancets; lancing devices for delivering medication; apparatus delivering pharmaceuticalsmedical pumps and injectors; infusion bolus handle for external patient's activation of the pump; infusion pumps cradles for mounting of infusion pumpscarrying and locking infusion pumps; infusion lock boxes for mounting of infusion pumpscarrying and locking infusion pumps
Classe 42
Computer system design for monitoringtrackinggatheringtransmittingcontrollingprocessingmeasuring and managing data regarding the delivery of pharmaceuticalsdrugsfluids and nutrition into the patient; software as a service SaaS services featuring software for monitoringtrackinggatheringtransmittingcontrollingprocessingmeasuring and managing data regarding the delivery of pharmaceuticalsdrugsfluids and nutrition into the patient; platform as a service PaaS featuring computer software platforms for monitoringtrackinggatheringtransmittingcontrollingprocessingmeasuring and managing data regarding the delivery of pharmaceuticalsdrugsfluids and nutrition into the patient; computer system design for monitoringtrackinggatheringtransmittingcontrollingprocessingmeasuring and managing data regarding the performance of the medical delivery devices of pharmaceuticalsdrugsfluids and nutrition; software as a service SaaS services featuring software for monitoringtrackinggatheringtransmittingcontrollingprocessingmeasuring and managing data regarding the performance of the medical delivery devices of pharmaceuticalsdrugsfluids and nutrition; platform as a service PaaS featuring computer software platforms for monitoringtrackinggatheringtransmittingcontrollingprocessingmeasuring and managing data regarding the performance of the medical delivery devices of pharmaceuticalsdrugsfluids and nutrition; computer system design for monitoringtrackinggatheringtransmittingcontrollingprocessingmeasuring and managing data regarding the patient's behaviorreaction toconsumption and effectiveness of the pharmaceuticalsdrugsfluids and nutrition provided to the patient via medical delivery devices; software as a service SaaS services featuring software for monitoringtrackinggatheringtransmittingcontrollingprocessingmeasuring and managing data regarding the patient's behaviorreaction toconsumption and effectiveness of the pharmaceuticalsdrugsfluids and nutrition provided to the patient via medical delivery devices; platform as a service PaaS featuring computer software platforms for monitoringtrackinggatheringtransmittingcontrollingprocessingmeasuring and managing data regarding the patient's behaviorreaction toconsumption and effectiveness of the pharmaceuticalsdrugsfluids and nutrition provided to the patient via medical delivery devices; computer system design for use in medical delivery devices; software as a service SaaS services featuring software for use in medical delivery devices; platform as a service PaaS featuring computer software platforms for use with medical delivery devices
Publicações
Histórico de despachos e eventos da marca no USPTO.
51 publicações encontradas
RHRD
RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED
12/02/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
14/03/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
22/02/2023
FIMP
FINAL DISPOSITION PROCESSED
22/02/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/02/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/11/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/11/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
01/11/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
19/10/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
19/10/2022
GPNX
NOTIFICATION PROCESSED BY IB
23/08/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/08/2022
PUBO
PUBLISHED FOR OPPOSITION
16/08/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/07/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/07/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
27/07/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/07/2022
ALIE
ASSIGNED TO LIE
10/07/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/07/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
07/07/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/07/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
07/07/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/07/2022
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
06/07/2022
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
21/06/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
20/06/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/06/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/06/2022
GNFR
FINAL REFUSAL E-MAILED
07/06/2022
CNFR
FINAL REFUSAL WRITTEN
07/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/05/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/05/2022
ALIE
ASSIGNED TO LIE
12/05/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/05/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/05/2022
GNRT
NON-FINAL ACTION E-MAILED
09/05/2022
CNRT
NON-FINAL ACTION WRITTEN
09/05/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/03/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/03/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/03/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
27/11/2021
RFNT
REFUSAL PROCESSED BY IB
25/10/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
30/09/2021
RFRR
REFUSAL PROCESSED BY MPU
30/09/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
16/09/2021
CNRT
NON-FINAL ACTION WRITTEN
15/09/2021
DOCK
ASSIGNED TO EXAMINER
09/09/2021
MAFR
APPLICATION FILING RECEIPT MAILED
22/05/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/05/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
13/05/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EITAN MEDICAL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.